Skip to main content

Lumexa Imaging Holdings, Inc.

corporate_fare Company Profile

Lumexa Imaging Holdings, Inc.

LMRI·NASDAQ·Industrial Applications And Services·CIK 0002071288

Lumexa Imaging Holdings, Inc. is one of the largest national providers of diagnostic imaging services in the United States. As of December 31, 2025, the company and its affiliates operated the second largest outpatient imaging center footprint in the United States, spanning 188 centers across 13 states and including eight joint venture partnerships with health systems. Its centers are located in attractive metropolitan service areas (MSAs) that, according to the U.S. Census Bureau, saw average annual population growth of approximately 1.4% on a center-weighted basis between 2020 and 2024—over two times the national average. The centers have convenient retail settings and operate with extended hours to facilitate easy access to care. The company has built a diversified network of approximately 102,000 referring physicians, representing more than 32,000 physician practices in 2025. It purchases best-in-class equipment and technology from innovative manufacturers and software companies, and its premium equipment, skilled technologists and subspecialized radiologists support advanced imaging referrals. Magnetic resonance imaging (MRI) and computed tomography (CT) referrals have been a key driver of revenue growth and accounted for 52% of consolidated revenue and 63% of system-wide revenue during the year ended December 31, 2025. The company's consolidated financial results include those of its wholly owned subsidiaries and its variable interest entities (VIEs); together, its wholly owned subsidiaries and VIEs owned 102 of the 188 centers it operated as of December 31, 2025.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for LMRI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 11 rated 8 or above. Recent SEC coverage for LMRI spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Lumexa 10-Q: Q3 Net Income $7.2M, But Material Weaknesses Persist and Controls Not Effective
  • Lumexa Posts Q3 Results, Reaffirms 8-10 New Centers for 2026
  • Lumexa Q3: Net Income Turns Positive at $7.2M, Adjusted EPS Guidance Raised to $0.86-$0.90
  • Lumexa Imaging Reports Q2 Profitability, Strong Operating Cash Flow
  • Lumexa Imaging Swings to Q2 Profit, Reiterates 2026 Outlook

Short Interest & Short Volume

6.00 days to cover

FINRA reported short interest of 1,807,730 shares in LMRI as of the October 30, 2026 settlement, a 5.8% decrease from the prior period — about 6.0 days to cover at its recent average daily volume. On November 20, 2026, 59.8% of LMRI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,807,730 shares as of October 30, 2026
Change vs prior period▼ 5.8%
Days to cover6.00 at avg daily volume of 301,306
Daily short volume (FINRA facilities)59.8% of 130,749 shares on November 20, 2026
5-day average short volume54.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with L →
$14.26
52-week range · as of 2026-11-12 $6.45 – $19.45
Market cap
$1.37B
Volume
442.4K (1.2× avg)
3-mo avg 368.3K
Live data · 2026-11-22 12:43 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LMRI - Latest Insights

LMRI
Nov 12, 2026, 7:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.95
Real-time Price: $14.26 info
Change: -$1.69 (-11%) info
Market Cap: $1.371B info
LMRI
Nov 10, 2026, 4:08 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.92
Real-time Price: $14.26 info
Change: +$0.340 (+2%) info
Market Cap: $1.371B info
LMRI
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.92
Real-time Price: $14.26 info
Change: +$0.340 (+2%) info
Market Cap: $1.371B info
LMRI
Aug 13, 2026, 2:54 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $14.26 info
Change: +$1.96 (+16%) info
Market Cap: $1.371B info
LMRI
Aug 12, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $14.26 info
Change: +$2.26 (+19%) info
Market Cap: $1.371B info
LMRI
Aug 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.06
Real-time Price: $14.26 info
Change: +$2.20 (+18%) info
Market Cap: $1.371B info
LMRI
Jun 30, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.28
Real-time Price: $14.26 info
Change: +$2.98 (+26%) info
Market Cap: $1.371B info
LMRI
Jun 30, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.28
Real-time Price: $14.26 info
Change: +$2.98 (+26%) info
Market Cap: $1.371B info
LMRI
Jun 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.35
Real-time Price: $14.26 info
Change: +$6.91 (+94%) info
Market Cap: $1.371B info
LMRI
May 12, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $14.26 info
Change: +$3.76 (+36%) info
Market Cap: $1.371B info
LMRI
May 12, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.15
Real-time Price: $14.26 info
Change: +$3.11 (+28%) info
Market Cap: $1.371B info
LMRI
May 12, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $14.26 info
Change: +$3.76 (+36%) info
Market Cap: $1.371B info
LMRI
Mar 30, 2026, 5:32 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $7.97
Real-time Price: $14.26 info
Change: +$6.29 (+79%) info
Market Cap: $1.371B info
LMRI
Mar 26, 2026, 6:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.06
Real-time Price: $14.26 info
Change: +$3.20 (+29%) info
Market Cap: $1.371B info
LMRI
Mar 26, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.06
Real-time Price: $14.26 info
Change: +$3.20 (+29%) info
Market Cap: $1.371B info
LMRI
Mar 02, 2026, 9:12 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $14.14
Real-time Price: $14.26 info
Change: +$0.120 (+0.85%) info
Market Cap: $1.371B info
LMRI
Mar 02, 2026, 6:14 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.14
Real-time Price: $14.26 info
Change: +$0.120 (+0.85%) info
Market Cap: $1.371B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets